Sector portfolio · VC firm · United States

Digitalis Ventures' Biotech portfolio

Digitalis Ventures has backed 16 Biotech startups in rounds we track, $1.5B between them, shown by the stage each has reached. The best-funded is T-Therapeutics.

16startups backed
3stages
$1.5Braised between them
Series Bbiggest stage

Digitalis Ventures's whole portfolioDigitalis Ventures's profile

Series B

9

Stage not reported

4

Series A

3

Segment by segment

Series B

9 startups · $1.2B raised

  1. T-TherapeuticsT-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.United Kingdom$279M
  2. Cardurion PharmaceuticalsCardurion Pharmaceuticals is a clinical-stage biotechnology company founded in 2017, focused on developing innovative therapeuticsUnited States$260M
  3. Matchpoint TherapeuticsMatchpoint Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.United States$220M
  4. Nuvig TherapeuticsNuvig Therapeutics is advancing innovative and transformational therapies that are designed to induce natural mechanisms to restore immune.United States$161M
  5. EpiBiologicsEpiBiologics is a biotechnology company based in San Mateo, California, founded in 2022.United States$107M
  6. GRO BiosciencesGRO Biosciences, also known as GRObio, is a biotechnology company based in Cambridge, Massachusetts, founded in 2016.United States$87M
  7. Scout BioScout Bi is a biotechnology company that specializes in veterinary, animal health, and gene therapy.United States$53M
  8. PetMedixPetMedix is a pet therapeutics startup.United Kingdom$37M

Stage not reported

4 startups · $128M raised

  1. Bonum TherapeuticsBonum Therapeutics creates a technology platform to treat a wide range of diseases.United States$120M
  2. KenzenKenzen’s Mission is to harness the power of physiology data to predict and prevent industrial workforce injuries and improve productivity.United States$6.1M
  3. Onc.AIOnc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics.United States$2.0M
  4. GirihletGirihlet is a provider of rapid and accurate deep sequencing services with a unique focus on developing novel technologies.United States$500K

Series A

3 startups · $100M raised

  1. Switch TherapeuticsSwitch Therapeutics is a preclinical-stage biotechnology company founded in 2020, focused on developing innovative RNA interferencUnited States$52M
  2. Faeth TherapeuticsFaeth Therapeutics is a cancer metabolism company that focuses on nutrition treatments for cancer patients.United States$25M
  3. Neion BioAt Neion Bio, we use breakthroughs in genetic engineering and stem cell biology to reinvent the entire manufacturing process for bUnited States$23M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Digitalis Ventures as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Portfolio mapDigitalis Ventures portfolio map28 startups · $1.6BCo-investorsWho invests with Digitalis Ventures27 co-investorsSector portfolioTechstars' AI portfolio336 startups · $4.9BSector portfolioAlumni Ventures' AI portfolio302 startups · $36BSector portfolioAndreessen Horowitz's AI portfolio259 startups · $426BSector portfolioGeneral Catalyst's AI portfolio226 startups · $179B

Raising from investors like Digitalis Ventures?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps